Diaceutics PLC
DXRX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 35.7% | 21.5% | 39.9% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 87.9% | 83.2% | 72% | 75.8% |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 8.6% | 10% | 18.5% | 16.8% |
| Net Income | -£0 | -£0 | £0 | £0 |
| % Margin | -5.3% | -7.4% | 3.7% | 4% |
| EPS Diluted | -0.02 | -0.021 | 0.008 | 0.007 |
| % Growth | 2.4% | -346.4% | 27.3% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | £0 | -£0 |